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Integrated productive haemopoeisis is fundamental 
to a successful immune response. Neutrophils, 
monocytes, eosinophils and basophils are essential 
components of the primary innate immune response 
and, further, initiate the secondary immune 
response by processing and presenting pathogenic antigens to 
the adaptive immune cells in the lymph nodes. After antigenic 
stimulation, the lymphocytes respond via T-cell-dependent cellular 
and B-cell-dependent humoral immune reactions.[1] A laboratory-
derived immunohaematological profile usually includes full blood 
count parameters, a white blood cell (WBC) differential count and 
lymphocyte subsets (T, B and natural killer cells). Lymphocyte 
subsets are further defined to provide important physiological and 
functional information such as the proportions of naïve, memory and 
activated T and B cells.
Comprehensive immunohaematological analysis is therefore 
used to screen paediatric patients for underlying immune 
suppression associated with primary immunodeficiency such 
as X-linked agammaglobulinaemia and severe combined 
immunodeficiency. It can also be used to exclude secondary 
immunodeficiency caused by overwhelming infections such as 
HIV, parvovirus, hepatitis B and tuberculosis,[2] and primary T-cell 
and B-cell as well as post-transplantation[3,4] lymphoproliferative 
disorders.
Although the optimal approach to assessing and monitoring 
immunohaematological status is to record individual patient baseline 
values prior to infection or clinical illness, this is not generally 
feasible. Standard clinical and laboratory practice is to compare the 
patient’s results with established reference intervals (that reveal the 
expected immunohaematological intervals of 90 - 95% of a ‘normal 
healthy population’[5]). Currently, the paediatric full blood count and 
lymphocyte subset reference intervals used by the National Health 
Laboratory Service (NHLS) in South Africa (SA) are taken from 
two international reference interval publications.[2,6] Differences in 
reference intervals attributed to ethnicity, diet, endemic infections, 
altitude, laboratory testing protocols and statistical methodologies 
used[7,8] suggest that international data sets may not necessarily be 
appropriate for local use in SA.
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Background. The paediatric full blood count and lymphocyte subset reference intervals used by the National Health Laboratory Service 
(NHLS), South Africa (SA), are taken from two international reference interval publications. Differences in reference intervals suggest that 
international data sets may not be appropriate for use in SA.
Objective. To study immunohaematological values of a group of clinically healthy children from an informal settlement in Cape Town, SA, 
to assess whether international paediatric reference intervals used by the NHLS are appropriate.
Methods. A cross-sectional study of 207 female and 174 male HIV-uninfected children living in an informal settlement in Cape Town 
was performed. Full blood counts, automated differential counts and lymphocyte subset analysis were done using internationally accepted 
technologies. Data were categorised by age and reference intervals compiled using medians and 95% confidence intervals (CIs). Gender 
comparisons were calculated by non-parametric tests.
Results. Although median and 95% CI values differed slightly, physiological trends for red cell, platelet, white blood cell differential 
and lymphocyte subsets were similar to international reference intervals currently in use at the NHLS. Benign ethnic neutropenia 
was not a significant finding, and gender-specific intervals were not necessary until 12 years of age. Lower overall median values 
for haemoglobin and haematocrit, and higher median values for mean cell volume and red cell distribution width, were noted. 
Assessment of haemoglobin, red cell distribution width and calculated Mentzer ratios suggested underlying iron deficiency in 14.2% 
of participants.
Conclusion. Paediatric immunohaematological reference intervals observed in this study are similar to, and support continued use of, 
international paediatric reference intervals. Underlying iron and related nutritional deficiencies may be contributing to lower haemoglobin 
levels noted in local children. A larger nationwide study, including all ethnic groups, is recommended.
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Objective
An opportunity to establish whether the reference interval sets[2,6] 
used are representative of local children’s full blood count and 
lymphocyte subset reference intervals presented itself during a recent 
clinical paediatric study at a child wellness clinic in Cape Town 
(H Payne et al. – unpublished data). The aim of this report was to 
establish reference intervals of full blood count and lymphocyte 
subset values in a cohort of apparently healthy SA children of diverse 
ethnicity, residing in a semi-informal settlement in Cape Town, SA, 
to assess the appropriateness of the full blood count and lymphocyte 
subset paediatric reference intervals currently used in the NHLS.
Methods
This was a cross-sectional study performed on 381 clinically healthy, 
HIV-uninfected children from the Wesbank semi-informal settlement 
in Cape Town. In Wesbank,[9] 27% of adults are unemployed, 62% 
have not completed their complete education to grade 12 level, and 
39% of households earn <R19 200 per year. Sixteen per cent of the 
population lives in informal dwellings, and 5% of the population is 
>65 years of age. The infant mortality rate is 23.2/1 000 live births, 
7% of babies are born to mothers aged <18 years, and 20% of babies 
weigh <2 500 g at birth.
There were 207 female and 174 male participants, with an age 
range of 2 weeks - 12.6 years. Each age group had an approximately 
50:50 male-to-female ratio. The children were black Africans (n=85) 
or of mixed ethnic ancestry (n=296). An attending paediatrician 
confirmed that the children were clinically healthy and well 
nourished on the day of phlebotomy. Wellness criteria included: (i) 
previous registration at the child wellness clinic; (ii) attendance with 
the biological mother and Road-to-Health card; (iii) a documented 
clinical history without current infection (defined as within the 
last week) or chronic medical conditions; and (iv) no prescribed 
medications. The Stellenbosch University Human Ethics Committee 
approved the study (M12/01/005).
Venous blood samples were collected into dipotassium EDTA, 
transported and stored at 20ºC (standard deviation 4ºC) prior 
to preparation and analysis. All testing was completed within 24 
hours of collection. Rapid HIV antibody analysis (Alere Determine, 
USA) confirmed that the participants were HIV-seronegative on 
the day of phlebotomy. An automated full blood count and white 
cell differential analysis was performed using a Beckman Coulter 
LH-750 Haematology Analyser (Beckman Coulter, USA). Samples 
were examined for the following parameters: total white blood cell 
(WBC) count and five-part automated differential count, red blood 
cell (RBC) count, haemoglobin (Hb), haematocrit (Hct), mean cell 
volume (MCV), red cell distribution width (RDW) and platelet 
(Plt) count. Blood films were reviewed manually to visually confirm 
automated differential counts and exclude gross morphological 
abnormalities. A Mentzer index (MCV/RBC)[10-12] was calculated 
for each participant. Dual-platform absolute lymphocyte subset 
counts and percentages were prepared using the Becton Dickinson 
FACSLyse/wash method (BDIS, USA). Samples were stained using 
the following directly labelled antibodies: CD3 APC, CD3 FITC, 
CD16 PE, CD19 FITC, CD45 PerCP, CD45RO PE, CD45RA FITC, 
HLA DR APC (BDIS) and CD4 FITC, CD8 PE and CD56 PE 
(Beckman Coulter). All samples were analysed on a FACSCalibur 
flow cytometer (Becton Dickinson, USA) using CellQuest analysis 
software (Becton Dickinson). The accuracy of the full blood count 
and lymphocyte subset values was subject to strict manufacturer 
and internationally recommended internal and external quality 
assurance procedures. Laboratories performing testing are 
accredited under the South African National Accreditation System 
(certificate numbers M0025A and M0106B) and subscribe to 
the NHLS National Quality Assessment programmes and the 
UK National External Quality Assessment Schemes to confirm 
longitudinal accuracy of all laboratory parameters.
Statistical analysis
The Clinical and Laboratory Standards Institute Approved Guideline 
(3rd edition) for defining and establishing reference intervals was 
used to determine and calculate the reference intervals.[5] No data 
points were removed from statistical analysis, as sample integrity 
and testing quality were closely monitored (and ensured) throughout 
the study. The data were categorised into the following age groups: 
0 - 3 months, 3 - 6 months, 6 - 12 months, 1 - 2 years, 2 - 6 years, 
6 - 12 years and >12 years, in keeping with similar international 
publications. Differences between genders were calculated with the 
non-parametric Mann-Whitney U-test and the reference intervals 
were reported as medians with 95% confidence intervals (CIs). Data 
analysis was performed using Microsoft Excel (Frontline Systems 
Inc., USA), Stata version 12 (StataCorp LP, USA) and GraphPad 
Prism 5 Software (GraphPad Software, USA).
Results
Table 1 summarises the values obtained for the full blood count and 
white cell differential parameters. Table 2 summarises the immune 
monitoring values, i.e. lymphocyte subsets, activated T cells and 
naive and memory subsets. No gender-specific statistically significant 
differences (Mann-Whitney p-values <0.05) were noted across any 
of the age groups for any of the full blood count parameters or 
lymphocyte subsets analysed. The Mentzer index, RDW and Hb 
values for participants identified with possible iron deficiency are 
summarised in Table 3.
Discussion
RBC parameters
In this study, the overall median RBC, Hb and Hct values increased 
from infancy to 12 years of age, with a cumulative increase of ±24% 
for RBCs (3.50 v. 4.60 × 1012/L), ±17% for Hb (10.6 v. 12.8 g/dL) 
and ±18% for HCT (0.31 v. 0.38 L/L between 0 - 3 months and 12 
years of age. The median MCV (92.2 fL) was highest at 0 - 3 months, 
decreasing steadily until approximately 2 years of age (72.5 fL); 
subsequently values increased, reaching previously reported adult 
values. Although the median RDW values were variable, no specific 
trends were noted across any of the paediatric age groups, falling 
within an interval of 13.5 - 16.3 fL. Analysis of the median values for 
RBC parameters and comparison with published literature confirms 
that the RBC parameters noted (Fig. 1) are in keeping with ‘normal’ 
physiological anaemia of childhood.[1] Increasing physiological 
demands for RBCs result in an overall decreased median Hb 
concentration and production of smaller RBCs (decreased median 
MCV),[6] with greater variation in size (increased median RDW). The 
MCV begins to decrease in healthy neonates after ±1 week, and RBC 
production increases when the Hb drops to a level of about 11 g/dL 
(at ±2 months of age), attributable to reduced red cell lifespan (60 - 
80 days v. 120 days for an adult), influence of erythropoietin,[1] etc.
No statistically significant gender-related differences in RBC 
parameters were noted until 12 years of age (p>0.05). Although gender-
specific discrepancies have been noted previously in the literature, they 
are more evident from puberty and are attributed to the hormonal 
influences of oestrogen and androgens (Hb in males is reported to 
increase by as much as 2 g/dL in response to testosterone[13]). Although 
not shown in this study, ethnicity and altitude have been noted to 
contribute to RBC parameter variation[6] in other studies.
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The RBC parameter variation, particularly in median Hb (~1 - 2 g/ dL 
lower) and Hct (~4 - 7% lower), across all age groups may be attributed 
to a combination of ethnicity and altitude. However, subclinical iron 
deficiency and/or mild anaemia could not be ruled out. Although 
iron deficiency and other metabolic disorders, including vitamin B12 
and folate deficiencies, were not formally excluded in this cohort, 
haematological indices and the Mentzer index calculation were 
assessed.[10] Iron deficiency was suspected if a concurrent Hb <10 g/ dL, 
RDW >15%[11] and Mentzer index >13[10,12] was found. As noted in 
another local adult reference interval study,[14] the findings suggested 
that 14.2% (54/381) of the children tested in this study had possible iron 
deficiency (Table 3). Further studies are required to confirm this finding.
Platelets
The overall median Plt counts were highest at 0 - 3 months 
(420 × 109/L) and were comparable to adult values described 
previously.[1,6] However, although the Plts remained within adult 
reference limits, they showed a steady decrease of approximately 
33% until 12 years of age (280 × 109/L) (Fig. 2). The median Plt 
count of the cohort appeared to stabilise at ±12 years of age, similar 
to reference intervals currently in use and a previously published 
local adult study.[15] Individual gender-specific differences become 
apparent at puberty as a result of hormonal influences. In girls, Plt 
counts increase by approximately 25 × 109/L owing to the effect of the 
hormone oestradiol.[13] Additional increases are linked to the onset of 
menstruation and prevalence of iron deficiency anaemia.[1,6]
WBC parameters
Total white cell and differential count
The median total WBC count increased from 9.6 × 109/L at 0 - 3 
months, reaching a peak of 12 × 109/L at 12 months. Thereafter, 
median WBC counts declined to reach adult values[6] at 12 years 
Table 1. Full blood count calculated medians and 95% CIs for the study group
Age ranges
0 - 3 months
(n=45)
3 - 6 months 
(n=40)
6 - 12 months 
(n=54)
1 - 2 years 
(n=79)
2 - 6 years 
(n=118)
6 - 12 years 
(n=37)
>12 years 
(n=8)
RBCs (× 1012/L) 3.5
(2.7 - 4.4)
4.2
(3.1 - 4.9)
4.4
(3.9 - 5.2)
4.4
(3.9 - 5.1)
4.3
(3.9 - 4.8)
4.2
(3.8 - 4.7)
4.6
(4.0 - 5.2)
Hb (g/dL) 10.6
(8.7 - 14.7)
11.4
(8.5 - 12.7)
10.8
(9.5 - 13.1)
10.8
(8.7 - 12.5)
11.2
(9.4 - 12.5)
11.8
(10.0 - 13.1)
12.8
(11.1 - 13.3)
Hct (L/L) 0.31
(0.25 - 0.41)
0.34
(0.25 - 0.38)
0.32
(0.28 - 0.39)
0.32
(0.27 - 0.37)
0.34
(0.29 - 0.38)
0.35
(0.31 - 0.38)
0.38
(0.32 - 4.00)
MCV (fL) 92.2
(82.2 - 99.4)
79.2
(68.7 - 88.6)
73.5
(66.8 - 81.2)
72.5
(64.5 - 82.2)
78.9
(64.5 - 86.4)
83.2
(74.3 - 87.7)
81.1
(75.4 - 86.8)
RDW (%) 14.7
(12.8 - 18.2)
13.5
(11.7 - 16.8)
15.9
(13.4 - 21.3)
16.3
(14.1 - 20.8)
14.8
(12.8 - 19.4)
13.9
(12.7 - 15.9)
13.9
(13.3 - 16.3)
Plt (× 109/L) 420
(243 - 581)
390
(228 - 687)
367
(253 - 610)
349
(192 - 551)
326
(197 - 471)
319
(206 - 454)
280
(180 - 371)
WBCs (× 109/L) 9.6
(5.7 - 14.9)
10.4
(6.9 - 19.7)
12.0
(5.3 - 20.0)
10.7
(6.9 - 18.5)
8.7
(5.8 - 13.6)
7.6
(4.0 - 10.0)
8.6
(4.9 - 13.0)
Neutrophils (%) 24.1
(15.6 - 39.0)
29.6
(11.6 - 48.8)
31.7
(13.0 - 52.3)
31.5
(20.0 - 51.1)
42.0
(25.0 - 61.2)
48.2
(28.4 - 65.3)
54.4
(45.5 - 57.2)
Neutrophils (× 109/L) 2.36
(1.26 - 5.20)
2.88
(1.22 - 8.11)
3.99
(1.13 - 8.08)
3.55
(1.79 - 7.87)
3.63
(1.59 - 6.64)
3.69
(1.85 - 6.33)
4.19
(2.60 - 7.30)
Lymphocytes (%) 60.0
(49.0 - 72.8)
58.8
(42.3 - 77.5)
58.0
(36.8 - 73.9)
57.0
(37.7 - 69.0)
43.4
(26.1 - 62.1)
37.5
(21.5 - 60.9)
35.1
(27.7 - 45.8)
Lymphocytes (× 109/L) 5.56
(3.23 - 11.07)
6.12
(3.79 - 12.43)
6.20
(3.10 - 11.45)
5.75
(3.58 - 10.58)
3.81
(1.93 - 6.11)
2.71
(1.50 - 3.89)
2.85
(1.78 - 3.95)
Monocytes (%) 11.0
(5.0 - 18.3)
7.9
(3.2 - 16.6)
8.0
(2.8 - 13.4)
7.0
(3.0 - 12.0)
6.0
(2.5 - 11.0)
5.3
(1.6 - 11.2)
6.1
(4.2 - 8.0)
Monocytes (× 109/L) 1.03
(0.52 - 2.40)
0.97
(0.32 - 2.37)
0.89
(0.30 - 1.93)
0.73
(0.29 - 1.61)
0.53
(0.20 - 1.06)
0.38
(0.12 - 0.97)
0.46
(0.22 - 0.75)
Eosinophils (%) 3.0
(1.0 - 6.3)
3.0
(0 - 10.0)
3.1
(1.0 - 8.0)
3.1
(0 - 10.0)
5.9
(1.5 - 18.1)
4.8
(0.9 - 12.9)
6.8
(1.1 - 16.0)
Eosinophils (× 109/L) 0.25
(0.07 - 0.89)
0.33
(0 - 1.24)
0.29
(0.05 - 1.34)
0.32
(0 - 1.37)
0.51
(0.11 - 1.20)
0.27
(0.10 - 1.16)
0.50
(0.06 - 1.05)
Basophils (%) 0.2
(0 - 1.1)
0.2
(0.1.1)
0.3
(0 - 1.3)
0.2
(0 - 1.0)
0.3
(0 - 1.0)
0.3
(0 - 0.8)
0.3
(0 - 0.4)
Basophils (× 109/L) 0.02
(0 - 0.11)
0.03
(0 - 0.12)
0.03
(0 - 0.17)
0.02
(0 - 010)
0.03
(0 - 0.08)
0.02
(0 - 0.04)
0.03
(0 - 0.10)
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Table 2. Measured immune monitoring data for the study group, medians and 95% CIs
Age ranges
0 - 3 months  
(n=45)
3 - 6 months  
(n=40)
6 - 12 months  
(n=54)
1 - 2 years 
(n=79)
2 - 6 years  
(n=118)
6 - 12 years  
(n=37)
>12 years 
(n=8)
Cell marker (cells/ml), 
median (95% CI)
CD3+ 3 650
(2 028 - 7 625)
3 999
(2 341 - 8 451)
4 212
(1 795 - 7 334)
3 787
( 2 392 - 6 616)
2 652
(1 360 - 4 202)
1 853
(1 017 - 2 913)
1 944
(1 146 - 2 544)
CD4+ 2 656
(1 520 - 5 160)
2 927
(1 573 - 5 441)
2 474
(1 085 - 4 562)
2 190
(1 374 - 3 928)
1 579
(816 - 2 705)
1 092
(568 - 2 013)
1 205
(724 - 1 785)
CD8+ 949
(428 - 2 478)
1 135
(593 - 3 176)
1 355
(622 - 3 244)
1 280
(669 - 3 247)
970
(414 - 1 599)
648
(340 - 1 210)
704
(318 - 980)
Ratio CD4+/CD8+  2.58
(1.29 - 5.49)
2.33
(1.19 - 4.96)
1.70
(0.90 - 3.92)
1.69
(0.78 - 3.88)
1.80
(0.91 - 3.13)
1.67
(0.95 - 2.47)
1.74
(1.58 - 2.63)
CD19+ 835
(351 - 1823)
1 179
(666 - 3 310)
1 037
(485 - 2 348)
1 156
(610 - 2 699)
584
(274 - 1 468)
322
(163 - 563)
303
(105 - 623)
CD3+HLA–DR+ 172
(94 - 709)
222
(90 - 1 361)
387
(157 - 916)
365
(142 - 1 069)
217
(92 - 507)
124
(56 - 284)
157
(54 - 205)
CD4+HLA–DR+ 117
(45 - 228)
129
(45 - 380)
107
(44 - 229)
125
(56 - 282)
84
(34 - 153)
49
(20 - 137)
60
(23 - 77)
CD8+HLA–DR+ 46
(10 - 487)
99
(21 - 950)
213
(58 - 699)
199
(44 - 849)
112
(29 - 414)
65
(29 - 168)
84
(27 - 131)
CD4+CD45+RA+ 1 828
(954 - 4 064)
2 383
(1 200 - 4 049)
1 749
(793 - 3 700)
1 687
(930 - 2 655)
944
(388 - 2  018)
603
(92 - 1 278)
551
(344 - 1 086)
CD4+CD45+RO+ 868
(261 - 1 801)
634
(314 - 1 384)
576
(359 - 1 293)
634
(343 - 1 218)
562
(343 - 1 218)
523
(305 - 845)
660
(311 - 708)
 Ratio CD4+ naive/
memory 
2.6
(0.74 - 7.00)
3.72
(1.55 - 6.45)
2.83
(1.19 - 5.51)
2.57
(1.35 - 5.64)
1.76
(0.71 - 3.69)
1.15
(0.10 - 2.48)
1.21
(0.76 - 1.60)
CD8+CD45+RA+ 812
(370 - 2 044)
873
(402 - 2 323)
974
(443 - 1 939)
964
(459 - 2 688)
719
(295 - 1 247)
466
(258 - 800)
425
(200 - 731)
CD8+CD45+RO+ 146
(50 - 683)
259
(81 - 1174)
337
(83 - 1 583)
292
(72 - 1 162)
188
(69 - 532)
159
(48 - 455)
213
(68 - 339)
 Ratio CD8+ naive/
memory  
4.93
(1.48 - 14.00)
3.40
(0.94 - 10.60)
3.36
(0.81 - 14.30)
3.43
(1.16 - 12.90)
3.56
(1.25 - 9.98)
2.86
(1.24 - 6.92)
2.52
(1.06 - 3.66)
CD16+CD56+ 489
(179 - 1 310)
399
(137 - 1 699)
367
(117 - 1 860)
435
(111 - 1 372)
284
(120 - 782)
214
(52 - 697)
277
(128 - 642)
CD3–CD56+ 448
(189 - 1 450)
396
(126 - 1 647)
368
(123 - 1 840)
385
(125 - 1 253)
283
(119 - 744)
219
(61 - 680)
294
(136 - 624)
Cell marker, % (95% CI)
CD3+ 69.3
(58.0 - 79.2)
67.8
(47.0 - 79.7)
68.3
(47.3 - 76.2)
67.0
(52.4 - 76.2)
70.5
(54.6 - 79.3)
71.8
(50.7 - 80.5)
64.5
(56.2 - 74.5)
CD4+ 49.5
(37.6 - 63.0)
45.9
(37.6 - 63.0)
41.2
(26.7 - 57.8)
39.7
(26.5 - 56.3)
41.6
(30.2 - 53.8)
41.9
(29.2 - 54.2)
42.0
(37.7 - 55.3)
CD8+ 18.2
(10.7 - 28.1)
19.6
(11.4 - 30.2)
24.1
(12.7 - 33.9)
24.4
(13.7 - 35.3)
24.5
(15.1 - 35.7)
25.9
(15.2 - 32.3)
23.3
(17.2 - 26.8)
Ratio CD4+/CD8+ 2.58
(1.29 - 5.49)
2.33
(1.19 - 4.96)
1.70
(0.90 - 3.92)
1.69
(0.78 - 3.88)
1.80
(0.91 - 3.13)
1.67
(0.95 - 2.47)
1.74
(1.58 - 2.63)
CD19+ 15.5
(8.0 - 29.5)
20.1
(10.5 - 38.7)
18.6
(9.3 - 33.5)
20.0
(10.7 - 33.0)
15.7
(9.4 - 30.5)
11.5
(8.4 - 18.0)
12.1
(5.9 - 17.1)
CD3+HLA–DR+ 5.1
(2.6 - 14.9)
5.6
(2.4 - 20.7)
9.7
(3.6 - 19.3)
9.0
(3.0 - 19.6)
8.0
(4.0 - 19.9)
6.9
(3.1 - 16.0)
7.3
(4.0 - 10.4)
Continued ...
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of age, with an overall 10% decrease in 
median total WBC counts between 
0  - 3 months and 12 years of age (9.6 v. 
8.6  ×  109/L). Between 0 - 3 months and 
12 years of age, the overall median absolute 
neutrophils increased by 44% (2.36 × 109L v. 
4.19 × 109L) and lymphocytes decreased by 
49% (5.56 × 109L v. 2.85 × 109L). Monocyte 
counts decreased by 55% (1.03 × 109L v. 
0.46 × 109L), while eosinophils and basophils 
increased by 50% (0.25 × 109L v. 0.50 × 109L) 
and 33% (0.02 × 109L v. 0.03 × 109L), 
respectively. These trends were also noted 
in the corresponding relative neutrophil, 
lymphocyte, monocyte, eosinophil and 
basophil percentage values. Lymphocytes 
are the predominant WBC until ±4 years 
of age and then decline, with neutrophils 
becoming increasingly predominant as the 
child grows.[6] This study confirmed this 
observation, showing a median lymphocyte 
count of 5.75 × 109/L v. 3.55 × 109/L for 
neutrophils at 1 - 2 years, with lymphocyte 
numbers decreasing to 2.71 × 109/L and 
neutrophils increasing to 3.69 × 109/L by 
6 - 12 years of age (Fig. 3). Neutrophil 
reference intervals calculated from this 
local paediatric population were in keeping 
with those reported from westernised 
countries.[6] These are higher than intervals 
reported from other African countries,[7,8] 
where benign genetic neutropenia, which 
may be linked to the Duffy-null trait, is 
thought to confer protection against Plasmo­
dium vivax malaria.[16] The similarity of 
this locally derived neutrophil reference 
interval to westernised countries could 
also be attributed to the large number of 
participants of mixed ethnic ancestry in this 
study (n=296).
Baseline eosinophil counts are reported 
to be increased in some African countries 
as a result of endemic parasitic infections.[8] 
Endemic parasitic infections are reported to be 
prevalent in children from the neighbouring 
Eastern Cape Province and, with the reported 
rapid influx of migrants from the Eastern 
Cape into Cape Town, increased eosinophil 
counts may have been expected in this study. 
However, the results from this and a previous 
SA study[15,17] reveal that eosinophil counts are 
low and in keeping with westernised countries. 
This is possibly the result of successful local 
implementation of deworming programmes 
in children that has ensured minimal 
helminthiasis, despite reports that >90% of 
children from the Eastern Cape region are 
infected by Ascaris and/or Trichuris.[18] Further, 
although a schistosomiasis prevalence of 73.2% 
was reported in a study of schoolchildren 
in the rural Eastern Cape, the eosinophil 
counts of this cohort of children suggest that 
schistosomiasis is also not prevalent in this 
population group.[19]
Table 2. (Continued) Measured immune monitoring data for the study group, medians and 95% CIs 
Age ranges
0 - 3 months  
(n=45)
3 - 6 months  
(n=40)
6 - 12 months  
(n=54)
1 - 2 years 
(n=79)
2 - 6 years  
(n=118)
6 - 12 years  
(n=37)
>12 years 
(n=8)
CD4+HLA–DR+ 4.0
(2.0 - 8.1)
4.2
(1.8 - 8.7)
4.3
(2.3 - 8.9)
5.6
(2.3 - 12.0)
5.7
(2.2 - 10.0)
4.3
(1.9 - 15.0)
4.2
(2.5 - 6.5)
CD8+HLA–DR+ 4.5
(1.6 - 28.7)
10.0
(1.5 - 38.9)
16.9
(5.4 - 35.1)
14.4
(4.5 - 46.2)
12.5
(4.6 - 30.1)
9.3
(5.1 - 23.9)
11.4
(6.4 - 17.8)
CD4+CD45+RA+ 72.2
(42.6 - 87.5)
78.8
(60.8 - 86.6)
73.9
(54.4 - 84.6)
72.0
(57.4 - 84.9)
63.8
(41.6 - 78.7)
53.5
(8.9 - 71.3)
54.6
(43.1 - 61.5)
CD4+CD45+RO+ 27.8
(12.5 - 57.4)
21.2
(13.4 - 39.2)
26.1
(15.4 - 45.6)
28.0
(15.1 - 42.6)
36.2
(21.3 - 58.4)
46.5
(28.7 - 91.1)
45.4
(38.5 - 56.9)
 Ratio CD4+ naive/
memory  
2.6
(0.7 - 7.0)
3.7
(1.6 - 6.5)
2.8
(1.2 - 5.5)
2.6
(1.4 - 5.6)
1.8
(0.7 - 3.7)
1.2
(0.1 - 2.5)
1.2
(0.8 - 1.6)
CD8+CD45+RA+ 83.1
(59.6 - 93.3)
77.3
(48.3 - 91.4)
77.1
(44.8 - 93.5)
77.4
(53.6 - 92.8)
78.1
(55.6 - 90.9)
74.9
(55.4 - 87.9)
71.6
(51.4 - 78.6)
CD8+CD45+RO+ 16.9
(6.7 - 40.4)
22.7
(8.6 - 51.7)
22.9
(6.5 - 55.2)
22.6
(7.2 - 46.4)
21.9
(9.1 - 44.4)
25.9
(12.6 - 47.0)
28.4
(21.4 - 48.6)
 Ratio CD8+ naive/
memory  
4.9
(1.5 - 14.0)
3.4
(0.9 - 10.6)
3.4
(0.8 - 14.3)
3.4
(1.2 - 12.9)
3.6
(1.3 - 10.0)
2.9
(1.2 - 6.9)
2.5
(1.1 - 3.7)
CD16+CD56+ 9.3
(3.6 - 22.5)
6.5
(3.0 - 17.7)
7.0
(3.2 - 18.4)
7.1
(2.4 - 20.0)
7.9
(3.4 - 18.1)
7.9
(2.9 - 26.9)
9.9
(6.0 - 19.2)
CD3–CD56+ 9.2
(4.0 - 20.7)
6.5
(3.0 - 18.5)
7.0
(3.2 - 17.8)
6.4
(2.5 - 19.1)
7.9
(3.6 - 17.5)
8.2
(3.1 - 26.3)
10.6
(5.9 - 19.8)
Table 3. Summary of Mentzer index, 
RDW and Hb values for boys and 
girls identified as having possible iron 
deficiency
Mentzer index RDW (%) Hb (g/dL)
Boys
27.0 15.5 7.3
15.8 16.9 7.7
17.5 18.4 7.9
27.1 15.5 8.2
14.5 19.4 8.3
15.6 16.8 8.7
15.4 17.1 8.8
12.4 19.8 8.8
13.0 19.4 8.8
35.6 15.6 8.9
16.0 24 8.9
14.0 18 9.2
18.8 20.5 9.2
16.4 20 9.2
19.5 21.5 9.3
15.5 18.4 9.4
32.8 15.3 9.4
14.5 20.8 9.5
Continued ...
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Lymphocyte subsets (T, B and natural 
killer cells)
Analysis of the absolute T, B and natural 
killer lymphocyte subset numbers showed 
a decreasing trend with age, in keep-
ing with previously described normal 
physiological total WBC and lymphocyte 
count intervals.[6] The median T-cell 
numbers decreased by ±47%, CD4-
positive cells by 55% and CD8-positive 
cells by 26%. As reported elsewhere, 
developmental changes in the composition 
of the peripheral B-cell pool are most 
noticeable up to 5 years of age, and the 
total number of B cells decreases with 
age. [1] In this cohort, the median number 
of CD19-positive B cells decreased by 36%, 
in keeping with international reports. [2] 
The median number of CD3–/CD16+/
CD56+ natural killer cells decreased by 
43% between 0 - 3 months and 12 years of 
age, in keeping with international trends 
and the current reference intervals used 
for reporting.[2]
Table 3. (Continued) Summary of 
Mentzer index, RDW and Hb values 
for boys and girls identified as having 
possible iron deficiency 
Mentzer index RDW (%) Hb (g/dL)
17.4 16.2 9.5
16.9 17.8 9.6
15.6 20.9 9.6
17.2 18.9 9.6
11.1 23.6 9.7
16.6 17.9 9.7
17.6 16.4 9.7
16.1 18.1 9.7
14.7 16.8 9.7
17.9 20.5 9.8
16.8 17.7 9.8
20.6 16.6 9.8
16.8 18 9.9
15.3 17.3 9.9
Girls
15.4 18.9 8.2
32.9 17.9 8.5
12.5 20.0 8.5
27.2 16.1 8.5
37.3 16.6 8.7
26.8 15.4 9.0
26.6 19.0 9.2
13.7 16.8 9.4
16.3 18.6 9.4
20.9 15.3 9.4
18.9 21.3 9.5
16.2 18.4 9.5
15.5 17.1 9.5
16.2 17.7 9.6
17.2 17.3 9.7
35.0 17.1 9.5
17.5 17.5 9.8
15.9 19.5 9.9
15.7 18.7 9.9
14.7 21.0 9.9
13.8 20.3 9.9
16.6 17.5 9.9
RBCs (× 1012/L)
Hb (g/dL)
<12
yr
5.0
4.5
4.0
3.5
3.0
2.5
2.0
1.5
1.0
0 - 3
mo.
14
12
10
8
6
4
2
0
3 - 6
mo.
6 - 12
mo.
2 - 6
yr
6 - 12
yr
1 - 2
yr
0.5
0
Fig. 1. Graphical representation of childhood physiological anaemia in this study group, similar to 
that previously described.[1] From ~3 ­ 6 months of age until 6 ­ 12 years of age, there is an inverse 
relationship between the median Hb and median RBC cell count. Between 6 and 12 years of age, the 
parameters converge and increase proportionally until adulthood.
1 - 2
yr
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yr
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3 - 6
mo.
6 - 12
mo.
2 - 6
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yr
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Plts (× 109/L)
Hb (g/dL)
Fig. 2. Comparison of the median Hb trend v. the median Plt count trend. As illustrated, while Hb 
increases steadily with age, Plts show a decreasing trend with age and only stabilise at puberty.
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Fig. 3. Comparison of median granulocyte numbers v. lymphocyte numbers. As illustrated, from about 
2 years of age lymphocyte numbers decrease markedly while granulocyte numbers stabilise and slowly 
begin to increase, in keeping with normal childhood physiological development.[1]
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T-cell activation
To assess T-cell activation, HLA-DR expression was measured 
on the total CD3+ T-cell population, on CD3+/CD8+ cytotoxic T 
lymphocytes and on CD3+/CD4+ helper T lymphocytes. HLA-DR 
expression is typically increased on T cells during activation and on 
CD8+ lymphocytes, specifically with increasing age.[20] In this cohort 
of children, an overall decrease of 9% in the total number of activated 
T cells between 0 - 3 months and 12 years of age (172  ×  106/L v. 
157 × 106/L) was noted. However, further investigation of the T-cell 
subsets showed a 51% decrease in activated CD3+/CD4+ lymphocytes 
(117 × 106/L v. 60 × 106/L) and a 55% increase in activated CD3+/
CD8+ cytotoxic T cells (46 × 106/L v. 84 × 106/L), as reported 
elsewhere.[2]
Naive and memory subsets
Analysis of CD45RA and CD45RO expression on CD3+/CD4+ 
T-helper lymphocytes in this study group was in keeping with 
international reports and showed consistent conversion of naive 
T-helper cells to memory T-helper cells from 0 - 3 months (ratio 2.6) 
across the range of paediatric age groups, to achieve a ratio of 1.21 
by 12 years of age.[2] Expression of CD45 isoforms, CD45RA and 
CD45RO, on CD4- and CD8-positive T-cells varies depending on 
the stage of maturation and the T-cell receptor response to antigenic 
stimulation.[21] CD45RA has been shown to be associated with CD4 
and be more efficient at promoting T-cell activation after T-cell 
receptor stimulation. Analysis of the CD45RA and CD45RO isoforms 
therefore remains important for monitoring immune suppression 
associated with infections such as HIV.[21]
Conclusion
Paediatric full blood count and lymphocyte subset reference intervals 
often differ between laboratories and across centres, and vary 
between populations and regions. Locally, a lack of comprehensive 
local paediatric full blood count and lymphocyte subset reference 
intervals has led to the use of internationally published reference 
intervals, which may not be appropriate for our local populations. 
Reference intervals reported here, derived from a cohort of children 
from an informal settlement in the Western Cape Province, SA, 
confirm expected active immunohaemopoeisis of childhood.[1,6]
Locally established reference intervals,[17,22] using limited 
participants from a single area (where a multitude of unknown 
factors may affect outcome), may not necessarily be appropriate for 
defining whether a particular individual’s blood counts are ‘normal’ 
(or not) if the individual is of different ethnic origin or socioeconomic 
background or lives in a different region. International Clinical 
Laboratory Standards Institute study guidelines are also not specific 
enough to exclude all variables that could affect each parameter 
studied.[5] The reference intervals reported here, although limited, do 
provide important insight into local paediatric reference intervals. In 
the absence of a local fully representative population study, including 
paediatric participants from across SA (with known ethnic, social 
and economic demographics), this study serves to validate the use 
of the published international reference intervals provided with 
NHLS paediatric immunohaematology laboratory reports. Ethical 
considerations will preclude studies on healthy, normal children. 
However, conducting similar studies during paediatric clinical trials 
in different regions across SA could provide valuable opportunities to 
extend this work. In the meantime, this article supports the continued 
use of the international paediatric reference intervals currently 
used by the NHLS for full blood count, white cell differential and 
lymphocyte subsets.
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